Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
General vs Spinal Anesthesia with ESP Block in Lumbar Decompression Surgeries
NCT05444751Phase 3Enrolling by invitation
- Sponsor
- Hospital for Special Surgery
- Start
- Mar 2022
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mepivacaine and bupivacaine hydrochloride 0.75% injection in lumbar disc herniation (LDH), lumbar disc disease and lumbar radiculopathy (2 arms), sponsored by Hospital for Special Surgery. Primary endpoint: Quality of Recovery 15 survey scores. Started Mar 2022; status: enrolling by invitation.
02
Drugs
mepivacainebupivacaine hydrochloride 0.75% injection
03
Conditions
lumbar disc herniation (LDH)lumbar disc diseaselumbar radiculopathy
Beyond the preview
Go deeper on NCT05444751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05444751.